ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ipr Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Ipr Pharmaceuticals, INC. (Ipr Pharmaceuticals, INC. Profit Sharing, Retirement And Savings Plan · EIN 66-0427378 · PN 002): $144.89M net assets, 186 active participants, and $0.00 per $10,000 (0.00 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorIpr Pharmaceuticals, INC.
Filing IdentifierIpr Pharmaceuticals, INC. Profit Sharing, Retirement And Savings Plan · EIN 66-0427378 · PN 002
Plan Category & State401(k) Defined Contribution (PR)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$144.89M
Active Participants186
Direct Admin Fee Rate$0.00 per $10,000 (0.00 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderVanguard
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($933,685, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI